Lamictal (Lamotrigine)

Lamotrigine blocks voltage‑gated sodium channels on neuronal membranes, keeping them in an inactive state. This reduces the release of excitatory neurotransmitters such as glutamate, which helps to stabilise neuronal firing and diminishes seizure activity and mood fluctuations.

The dosage of Lamictal is individualised by the prescribing clinician based on the patient’s condition, age, concomitant medications and response. Initial doses are typically low and are titrated upward to achieve therapeutic effect while minimising side‑effects.

The safety of lamotrigine in pregnancy and lactation is not fully established. It is classified as pregnancy category unknown, and clinicians weigh potential benefits against risks. Women who are pregnant or planning pregnancy should discuss alternatives and monitoring strategies with their healthcare provider.

To request Lamictal, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other anticonvulsants, lamotrigine offers a favourable profile for mood stabilisation and has a lower risk of cognitive side‑effects. However, it carries a risk of serious skin reactions, especially when combined with valproic acid, and requires careful titration, unlike some agents that have fixed dosing.

Lamictal should be stored at room temperature, below 25 °C, in its original packaging. Keep the tablet bottle tightly closed, protect it from moisture and direct sunlight, and store out of reach of children.

Lamictal is taken orally, usually as a tablet, with or without food. The exact timing and frequency are determined by the prescriber, who may advise taking the medication at the same time each day to maintain steady blood levels.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, blood dyscrasias, hepatic failure, and the emergence of suicidal thoughts or behaviours. Immediate medical attention is required if any of these symptoms appear.

Lamictal is contraindicated in individuals with a known hypersensitivity to lamotrigine or any of its excipients. Patients with a history of severe skin reactions to other medications should use it with caution, and it should be avoided in those taking interacting drugs without appropriate dose adjustments.